𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic/pharmacodynamic differentiation of pancreatic responsiveness in obese and lean children

✍ Scribed by N. Gupta; R. P. Hoffman; P. Veng-Pedersen


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
161 KB
Volume
26
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparative pharmacokinetics and pharmac
✍ Jerzy WΓ³jcicki; Maria Jaroszynska; Marek DroΕΊdzik; Andrzej Pawlik; Barbara Gawro πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 1 views

## Abstract The lipophilic beta‐adrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients. A total of 43 subjects were allocated into three study groups: (1) healthy, lean, normolipaemic vol

Chiral pharmacokinetics of rac-flurbipro
✍ Dr. William J. Wechter; Annette E. Bigornia; E. David Murray Jr.; Webster S. S. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 238 KB πŸ‘ 1 views

The route of administration of the NSAID, flurbiprofen (sq vs. PO) resulted in positive and negative results respectively with regard to enhanced cancellous and cortical bone accumulation in the immature rat. This pharmacokinetic study was an effort to understand the pharmacodynamic difference betwe

Pharmacokinetics and pharmacodynamics of
✍ Sonia I. Lugo; Zhongming Liang; Natalie D. Eddington πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 1 views

Mivacurium, a non-depolarizing neuromuscular blocking agent, consists of three isomers; trans-trans (57%), cis-trans (36%) and cis-cis (7%). The purpose of this study was to characterize the pharmacokinetics and pharmacodynamics of mivacurium after various inputs. Four beagle dogs weighing between 7

Influence of lovastatin on the pharmacok
✍ Kurt L. Berens; Kiumars Vadiei; Lane J. Brunner; Kishor M. Wasan; Dr. David R. L πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 591 KB

## Abstract The combined use of lovastatin, a hypolipidemic agent effective in the reduction of cholesterol levels, and the lipophilic immunosuppressant, cyclosporine, was studied in the obese rat model. Pharmacokinetics, immunosuppressive activity, lipid levels, and creatinine clearances were comp